Improving stone disease treatment by accurate phenotyping and risk stratification

$100,000U54FY2017DKNIH

Mayo Clinic Rochester, Rochester MN

Investigators

Linked publications & trials

Paper 39102294 Paper 38039384 Paper 36967473 Paper 36319741 Paper 35411063 Paper 35306035 Paper 35014212 Paper 34074247 Paper 34044181 Paper 34031587 Paper 33867205 Paper 33644833 Paper 33367720 Paper 32726309 Paper 31934946 Paper 31907321 Paper 31890054 Paper 31852738 Paper 31635759 Paper 31461349 Paper 31364377 Paper 31300088 Paper 31175141 Paper 30728476 Paper 30531469 Paper 30527866 Paper 30520657 Paper 30460525 Paper 30287145 Paper 30232135 Paper 30213974 Paper 30146423 Paper 30084728 Paper 29791142 Paper 29740846 Paper 29531098 Paper 29454545 Paper 29452705 Paper 29406740 Paper 29270519 Paper 28943700 Paper 28932781 Paper 28829430 Paper 28764885 Paper 28458443 Paper 28402129 Paper 28392615 Paper 28241103 Paper 28217694 Paper 28148559 Paper 27776839 Paper 27717761 Paper 27654929 Paper 27489300 Paper 27256549 Paper 27224260 Paper 27210573 Paper 27117801 Paper 27072072 Paper 26932693 Paper 26865949 Paper 26837814 Paper 26818529 Paper 26772639 Paper 26688770 Paper 26598423 Paper 26587926 Paper 26538444 Paper 26496550 Paper 26422682 Paper 26349951 Paper 26332888 Paper 26324901 Paper 26302388 Paper 26240296 Paper 26206452 Paper 26204304 Paper 26167684 Paper 26022722 Paper 25963767 Paper 25896425 Paper 25845008 Paper 25729563 Paper 25681832 Paper 25652357 Paper 25539242 Paper 25440821 Paper 25354237 Paper 25306481 Paper 25278549 Paper 25229337 Paper 25228763 Paper 25104803 Paper 25092598 Paper 25085645 Paper 25061988 Paper 25037635 Paper 24992333 Paper 24848936 Paper 24578335

Abstract

DESCRIPTION (provided by applicant): The overall goals of the Mayo Clinic Urology O'Brien Research Center are to develop new diagnostic strategies in order to accurately phenotype patients and thus apply improved individualized management strategies. We will pursue these goals via 4 interlinked multidisciplinary projects. Important and timely aims of the Mayo Clinic O'Brien Urology Research Center include: 1) Develop and validate a comprehensive low-dose stone-characterization exam using clinical dual-energy CT techniques in order to predict stone fragility, and to develop new CT methods capable of detecting the earliest possible precursor lesions. 2) Determine factors that produce NL precursor lesions including Randall's plaques and tubular plugs. 3) Define specific factors that increase the risk of kidney stones and their recurrence, and develop clinical prediction tools to help clinicians identify high-risk patients.

View original record on NIH RePORTER →